bibliographic resource 2582533 [br/2582533]
https://w3id.org/oc/corpus/br/2582533

is a
title
  • A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
publication date
  • 2015-01-01
contributor
format
identifier
part of